111 (YI) Liabilities and Shareholders Equity (2017 - 2025)
111 (YI) posted Liabilities and Shareholders Equity of $310.2 million for Q4 2025, down 11.04% sequentially from $348.7 million in Q3 2025, and down 20.07% YoY from $388.1 million in Q4 2024.
111 (YI) Liabilities and Shareholders Equity (2017 - 2025) Analysis & Trends
111 has reported Liabilities and Shareholders Equity for 9 years, with the latest figure at $310.2 million in Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 20.07% year-over-year to $310.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 billion (down 36.72% YoY) and the FY2025 annual result came in at $306.2 million, down 19.83% from the prior year.
- Liabilities and Shareholders Equity eased to $310.2 million in Q4 2025 per YI's latest filing, from $348.7 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $511.1 million in Q2 2021 and troughed at $342381.4 in Q2 2025.
- A 5-year average of $335.4 million and a median of $405.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity soared 88622.79% in 2022, then plunged 99.91% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $492.0 million in 2021, then decreased by 0.73% to $488.4 million in 2022, then slipped by 12.16% to $429.0 million in 2023, then decreased by 9.54% to $388.1 million in 2024, then retreated by 20.07% to $310.2 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $310.2 million, $348.7 million, and $342381.4 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 88.33 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 83.81 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 57.30 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 11.38 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | 189.63 Mn |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 74.55 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 2.11 Bn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 279.33 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 61.46 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 310.22 Mn |
| Sep 30, 2025 | 348.70 Mn |
| Jun 30, 2025 | 342,381.38 |
| Mar 31, 2025 | 358.76 Mn |
| Dec 31, 2024 | 388.10 Mn |
| Sep 30, 2024 | 431.73 Mn |
| Jun 30, 2024 | 383.81 Mn |
| Mar 31, 2024 | 405.05 Mn |
| Dec 31, 2023 | 429.03 Mn |
| Sep 30, 2023 | 460.66 Mn |
| Jun 30, 2023 | 435,486.50 |
| Mar 31, 2023 | 473,427.19 |
| Dec 31, 2022 | 488.43 Mn |
| Sep 30, 2022 | 429.46 Mn |
| Jun 30, 2022 | 463.40 Mn |
| Dec 31, 2021 | 492.04 Mn |
| Sep 30, 2021 | 484,046.99 |
| Jun 30, 2021 | 511.11 Mn |
| Mar 31, 2021 | 469.99 Mn |
| Dec 31, 2020 | 456.68 Mn |